Tom Lukas Kaufmann
Tom Lukas Kaufmann
Doctoral Researcher
Tom L. Kaufmann is a doctoral researcher affiliated with BIFOLD, the Max Delbrück Center for Molecular Medicine and the CompCancer graduate school. Prior to his PhD, he studied physics at Heidelberg University with a one year stay at University College London and was supported by the Studienstiftung des Deutschen Volkes throughout his studies.
- Cancer Evolution
- Tumor Heterogeneity
- Simulations of Cancer Cells
- Latent Space Representations
Alexander M. Frankell, Michelle Dietzen, Maise Al Bakir, Emilia L. Lim, Takahiro Karasaki, Sophia Ward, Selvaraju Veeriah, Emma Colliver, Ariana Huebner, Abigail Bunkum, Mark S. Hill, Kristiana Grigoriadis, David A. Moore, James R. M. Black, Wing Kin Liu, Kerstin Thol, Oriol Pich, Thomas B. K. Watkins, Cristina Naceur-Lombardelli, Daniel E. Cook, Roberto Salgado, Gareth A. Wilson, Chris Bailey, Mihaela Angelova, Robert Bentham, Carlos Martínez-Ruiz, Christopher Abbosh, Andrew G. Nicholson, John Le Quesne, Dhruva Biswas, Rachel Rosenthal, Clare Puttick, Sonya Hessey, Claudia Lee, Paulina Prymas, Antonia Toncheva, Jon Smith, Wei Xing, Jerome Nicod, Gillian Price, Keith M. Kerr, Babu Naidu, Gary Middleton, Kevin G. Blyth, Dean A. Fennell, Martin D. Forster, Siow Ming Lee, Mary Falzon, Madeleine Hewish, Michael J. Shackcloth, Eric Lim, Sarah Benafif, Peter Russell, Ekaterini Boleti, Matthew G. Krebs, Jason F. Lester, Dionysis Papadatos-Pastos, Tanya Ahmad, Ricky M. Thakrar, David Lawrence, Neal Navani, Sam M. Janes, Caroline Dive, Fiona H. Blackhall, Yvonne Summers, Judith Cave, Teresa Marafioti, Javier Herrero, Sergio A. Quezada, Karl S. Peggs, Roland F. Schwarz, Peter Van Loo, Daniël M. Miedema, Nicolai J. Birkbak, Crispin T. Hiley, Allan Hackshaw, Simone Zaccaria, TRACERx Consortium, Mariam Jamal-Hanjani, Nicholas McGranahan & Charles Swanton
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx
Sebastijan Hobor, Maise Al Bakir, Crispin T. Hiley, Marcin Skrzypski, Alexander M. Frankell, Bjorn Bakker, Thomas B. K. Watkins, Aleksandra Markovets, Jonathan R. Dry, Andrew P. Brown, Jasper van der Aart, Hilda van den Bos, Diana Spierings, Dahmane Oukrif, Marco Novelli, Turja Chakrabarti, Adam H. Rabinowitz, Laila Ait Hassou, Saskia Litière, D. Lucas Kerr, Lisa Tan, Gavin Kelly, David A. Moore, Matthew J. Renshaw, Subramanian Venkatesan, William Hill, Ariana Huebner, Carlos Martínez-Ruiz, James R. M. Black, Wei Wu, Mihaela Angelova, Nicholas McGranahan, Julian Downward, Juliann Chmielecki, Carl Barrett, Kevin Litchfield, Su Kit Chew, Collin M. Blakely, Elza C. de Bruin, Floris Foijer, Karen H. Vousden, Trever G. Bivona, TRACERx consortium, Robert E. Hynds, Nnennaya Kanu, Simone Zaccaria, Eva Grönroos, Charles Swanton
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling
Improved identification of cancer mutational processes
Xiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, Anca-Ioana Grapa, Hanyun Zhang, Alvin Ho Kwan Cheung, Juvenal Baena, Takahiro Karasaki, Claire Rachel Wilson, Marco Sereno, Selvaraju Veeriah, Sarah J. Aitken, Allan Hackshaw, Andrew G. Nicholson, Mariam Jamal-Hanjani, TRACERx Consortium, Charles Swanton, Yinyin Yuan, John Le Quesne & David A. Moore
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma
Thomas B. K. Watkins, Emma C. Colliver, Matthew R. Huska, Tom L. Kaufmann, Emilia L. Lim, Cody B. Duncan, Kerstin Haase, Peter Van Loo, Charles Swanton, Nicholas McGranahan, Roland F. Schwarz